At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Combination Therapy for the Treatment of Obstructive Sleep Apnea
In Brief
A clinical study evaluating Placebo pill, Sedative, and 2 other interventions for Sleep Apnea, Obstructive. Completed, enrolled 22 participants across 1 site.
Detailed Summary
In Obstructive sleep apnea (OSA), the upper airway closes over and over again during sleep. This leads to disrupted sleep (waking up during the night), daytime sleepiness, and an increased risk for developing high blood pressure. Currently, the best treatment for obstructive sleep apnea is sleeping with a mask that continuously blows air into the nose (i.e. Continuous positive airway pressure \[CPAP\] treatment). While CPAP treatment stops the upper airway from closing in most people, many people have difficulty sleeping with the mask in place and therefore do not use the CPAP treatment. This research study is being conducted to learn whether using a combination of therapies (i.e. a sedative and oxygen therapy) will improve OSA severity by altering some of the traits that are responsible for the disorder.
Study Details
Timeline
Interventions
Subjects will receive a sugar pill (in combination with room air) during their placebo arm studies
Subjects will receive eszopiclone (in combination with medical oxygen) during their treatment arm studies
Subjects will receive room air (in combination with a sugar pill) during their placebo arm studies
Subjects will receive medical grade oxygen (in combination with eszopiclone) during their treatment arm studies